{"id":55678,"date":"2023-04-11T15:05:24","date_gmt":"2023-04-11T13:05:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/"},"modified":"2023-04-11T15:05:24","modified_gmt":"2023-04-11T13:05:24","slug":"arteraai-and-american-cancer-society-announce-new-relationship","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/","title":{"rendered":"ArteraAI and American Cancer Society Announce New Relationship"},"content":{"rendered":"
\n

\nWith the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease<\/i><\/p>\n

SAN FRANCISCO & ATLANTA–(BUSINESS WIRE)–ArteraAI<\/a>, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new relationship today that will allow both parties to contribute to making progress against the more than 200 diseases we call cancer.<\/p>\n

<\/a><\/p>\n

\nThis announcement comes on the heels of ArteraAI\u2019s recent emergence from stealth mode<\/a>, with $90M in funding to support the <\/i>distribution of its flagship test in prostate cancer, the ArteraAI Prostate Test<\/a>. This is the first test to predict therapy benefit in localized prostate cancer. The funding will also foster the development of tests to support therapy personalization in other cancers.<\/p>\n

\n\u201cPutting the power of AI into clinicians’ hands to help personalize cancer treatment is no small feat,\u201d said Andre Esteva, co-founder and CEO of ArteraAI. \u201cThis is why it is essential to pick the right partners to propel our mission forward. We are honored to announce this strategic collaboration with the American Cancer Society as an advisor, and deeply value the organization\u2019s support and guidance as we continue to move forward in reducing health disparities and serving all those touched by cancer.\u201d<\/p>\n

\nRecently, the American Cancer Society launched IMPACT: Improving Mortality from Prostate Cancer Together, a commitment to using every facet of the organization to improve outcomes for all and reverse disparities for Black men. Studies<\/a> show prostate cancer diagnoses are currently on the rise, and Black men carry a disproportionate burden of prostate cancer occurrences in the U.S. with the world’s highest documented prostate cancer rate. Black men are also more than twice as likely to die<\/a> from the disease than other men.<\/p>\n

\n\u201cWe are thrilled to team up with ArteraAI, with the aligned mission of improving the lives of people with cancer,\u201d said Dr. Karen E. Knudsen, Chief Executive Officer of the American Cancer Society. \u201cWhile it will take a compilation of things to address health disparities in the area of cancer alone, innovative technology like ArteraAI\u2019s can increase shared decision-making with patients and clinicians, increase treatment adherence, and reduce stigma, which are a few of the immediate deterrents for many in marginalized communities when seeking prostate cancer care. Given the goal alignment between our organizations, we look forward to finding impactful ways to collaborate on reducing the burden of cancer.\u201d<\/p>\n

\nThe ArteraAI Prostate Test is a clinically available, laboratory-developed test. For more information or to order the test please visit ArteraAI<\/a>.<\/p>\n

\nAbout ArteraAI<\/span><\/b><\/p>\n

\nArteraAI is a leading precision medicine company developing AI tests to personalize therapy for cancer patients. Their test provides risk stratification and prediction of therapeutic benefit, including the first-ever predictive test for localized prostate cancer. It is clinically available through a CLIA-certified laboratory in Jacksonville, Florida, and can be ordered online at ArteraAI<\/a>.<\/p>\n

\nAbout The American Cancer Society<\/span><\/b><\/p>\n

\nThe American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 100 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit cancer.org<\/a> or call our 24\/7 helpline at 1-800-227-2345. Connect with us on Facebook<\/a>, Twitter<\/a>, and Instagram<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nLesley Swiger
\n
Antenna
\n
artera@antennagroup.com<\/a>
(312) 489-8440<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease SAN FRANCISCO & ATLANTA–(BUSINESS WIRE)–ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new relationship today that will allow … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55678","6":"format-standard","7":"category-industry"},"yoast_head":"\nArteraAI and American Cancer Society Announce New Relationship - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ArteraAI and American Cancer Society Announce New Relationship - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease SAN FRANCISCO & ATLANTA–(BUSINESS WIRE)–ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new relationship today that will allow ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-11T13:05:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230411005323\/en\/1760098\/21\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ArteraAI and American Cancer Society Announce New Relationship\",\"datePublished\":\"2023-04-11T13:05:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/\"},\"wordCount\":596,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005323\\\/en\\\/1760098\\\/21\\\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/\",\"name\":\"ArteraAI and American Cancer Society Announce New Relationship - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005323\\\/en\\\/1760098\\\/21\\\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg\",\"datePublished\":\"2023-04-11T13:05:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005323\\\/en\\\/1760098\\\/21\\\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005323\\\/en\\\/1760098\\\/21\\\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arteraai-and-american-cancer-society-announce-new-relationship\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ArteraAI and American Cancer Society Announce New Relationship\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ArteraAI and American Cancer Society Announce New Relationship - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/","og_locale":"en_US","og_type":"article","og_title":"ArteraAI and American Cancer Society Announce New Relationship - Pharma Trend","og_description":"With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the disease SAN FRANCISCO & ATLANTA–(BUSINESS WIRE)–ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American Cancer Society, a leading cancer-fighting organization, announce a new relationship today that will allow ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-11T13:05:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230411005323\/en\/1760098\/21\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ArteraAI and American Cancer Society Announce New Relationship","datePublished":"2023-04-11T13:05:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/"},"wordCount":596,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005323\/en\/1760098\/21\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/","url":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/","name":"ArteraAI and American Cancer Society Announce New Relationship - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005323\/en\/1760098\/21\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg","datePublished":"2023-04-11T13:05:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230411005323\/en\/1760098\/21\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230411005323\/en\/1760098\/21\/Full_Color_Primary_Vertical_NO_Padding_LT_BG_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arteraai-and-american-cancer-society-announce-new-relationship\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ArteraAI and American Cancer Society Announce New Relationship"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55678"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55678\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55678"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55678"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}